CTS Q1 Net Sales +10.7% to $139.2M; EPS $0.59, up 34.1%
CTS Corp. reported strong first-quarter 2026 results, with net sales increasing 10.7% to $139.2 million and diluted EPS growing 34.1% to $0.59. Net earnings also saw a significant rise of 28.6% to $17.2 million. The company reached an agreement in principle for a $7.61 million environmental settlement with the EPA for the Asheville Site, with CTS's portion estimated at $6.67 million. Additionally, CTS entered into a new $300 million revolving credit facility in November 2025, providing increased financial flexibility.
Key Highlights
- Net sales increased 10.7% to $139.2 million for Q1 2026.
- Net earnings rose 28.6% to $17.2 million for Q1 2026.
- Diluted EPS grew 34.1% to $0.59 for Q1 2026.
- Operating earnings increased 35.0% to $22.0 million for Q1 2026.
- Agreed in principle to a $7.61 million EPA environmental settlement for the Asheville Site.
- Transportation segment revenue was $60.2 million, up 2.85% year-over-year.
- Medical segment revenue was $24.5 million, up 28.15% year-over-year.
- Long-term debt stood at $62.5 million with a 4.75% weighted-average interest rate.
Price Impact
More from CTS
CTS Corp Q2 2026 Earnings Release & Conference Call Scheduled
CTS Appoints Pratik Trivedi as CEO; O’Sullivan Becomes Executive Chairman
CTS Promotes Pratik Trivedi to CEO; Kieran O’Sullivan Becomes Executive Chair